Zoetis (ZTS) Cost of Revenue (2012 - 2026)

Zoetis (ZTS) has 15 years of Cost of Revenue data on file, last reported at $641.0 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 3.72% year-over-year to $641.0 million in Q1 2026; TTM through Mar 2026 was $2.7 billion, a 0.33% change from a year earlier, with the FY2025 full-year figure at $2.7 billion, down 1.95% from the prior year.
• Cost of Revenue for Q1 2026 stood at $641.0 million, down from $712.0 million in the prior quarter.
• Over the last five years, Cost of Revenue for ZTS reached as high as $728.0 million in Q4 2023 and fell as low as $569.0 million in Q1 2022.
• Historically, Cost of Revenue has averaged $649.2 million across 5 years, with a median of $643.0 million in 2024.
• Across the five-year window, Cost of Revenue advanced 11.49% in 2023 and slipped 3.89% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $653.0 million in 2022, then climbed by 11.49% to $728.0 million in 2023, then slipped by 2.88% to $707.0 million in 2024, then gained by 0.71% to $712.0 million in 2025, then decreased by 9.97% to $641.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $641.0 million in Q1 2026, $712.0 million in Q4 2025, and $683.0 million in Q3 2025.